Study of rapid tests for Chagas diagnosis
Part of Infections clinical trials.
This trial is testing new rapid diagnostic tests to detect infection with Trypanosoma cruzi, which causes Chagas disease. It aims to find faster ways to diagnose people who may be at risk, such as pregnant women, blood donors, or those with possible chronic infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a pregnant woman, blood donor, organ transplant recipient, or have a suspected long-term Chagas infection.
- You are older than 10 months of age.
- You agree to take part and sign a consent form (or have a parent or guardian sign for you).
- You have not had any prior treatment for the parasite that causes Chagas disease.
- You do not have a weakened immune system (for example, from HIV or certain medications).
- You do not have any other condition that would make it hard to follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a shorter course of benznidazole (a medicine for Chagas disease) to the standard longer treatment. It aims to see if the shorter regimen works as well and is safe for people with confirmed Chagas infection.
This trial tests a new drug called LXE408 for people with chronic Chagas disease. It aims to see if the drug is safe and effective, and participants will also receive standard treatment with benznidazole.
This study is testing a new rapid diagnostic test that aims to help eliminate onchocerciasis (river blindness). The test will be checked in people with different types of filarial worm infections (or no infection) to see how well it can tell them apart.
This study is testing a quick, point-of-care test that checks for HIV, hepatitis B and C, and syphilis in pregnant women in the DR Congo. The goal is to see if the test works well so that more women can get screened and treated early, protecting both mother and baby.
This study evaluates a new rapid blood test that checks for HIV, hepatitis B, and syphilis all at once. Researchers want to make sure the test works well, is easy to use, and gives accurate results.
This trial tests if a single oral dose of acoziborole can safely stop the spread of the parasite that causes sleeping sickness (gambiense human African trypanosomiasis). If you've tested positive on a rapid screening test and haven't had treatment before, you might be able to help us find a simpler way to protect communities.
Hear when a new Chronic Chagas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.